Tian'an Technology Group LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

OTC.Pink
Tianan Technology Group achieves net income in 2024 following a strategic shift towards graphene production and health therapy, marking a significant turnaround from the previous year.
OTC.Pink
Tianan Technology Group Ltd. reports a shift in business model towards graphene-based health therapy amidst financial challenges and expresses substantial doubt about its ability to continue as a going concern.